AgeX Therapeutics, Inc. (AGE)

Free Cash Flow Growth

26.25%

TTM · Period ending:

AGE logo

AGE Free Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported26.25%
AGE TTM Free Cash Flow YoY % (-35.10% → 26.25%)
High-resolution chart · PNG

AGE free cash flow growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

AgeX Therapeutics, Inc. Free Cash Flow Growth — Trailing twelve months (TTM)
Period endingFree Cash Flow Growth
26.2484%
26.9242%
18.9829%
-87.9821%
-421.7003%
-231.5628%
-184.1282%
-77.5074%
14.7182%
-21.7899%
-31.3352%
-12.8332%
6.8277%
10.1006%
24.3921%
19.7618%
11.655%
18.1167%
-0.4861%
12.4958%
18.7519%
18.2377%
27.6271%
-8.1838%
-13.2792%
-31.2164%
-35.0969%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.